M(6)A modification in lipid metabolism and related diseases.

m 6 A modification plays a significant role in lipid metabolism and related diseases, with regulators like METTL3 and METTL14 involved in disease development and progression.

• Why it matters: Understanding how m 6 A regulates lipid processes is crucial because it may lead to novel therapeutic strategies for lipid metabolism disorders such as obesity, NAFLD, and atherosclerosis.
• What they did: The review systematically examines the mechanisms by which m 6 A influences lipid synthesis, catabolism, and transport, highlighting the roles of regulators like METTL3, METTL14, and FTO gene variants.
• The result: Targeting m 6 A regulators presents a promising therapeutic approach, although challenges remain, especially in developing FTO inhibitors for obesity and lipid-related diseases.